DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis
Xu Zhao(First Affiliated Hospital of Xi'an Jiaotong University), Yunfeng Zhang(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 19
Related Papers
PTP1B inhibition ameliorates inflammatory injury and dysfunction in ox‑LDL‑induced HUVECs by activating the AMPK/SIRT1 signaling pathway via negative regulation of KLF2
|Experimental and Therapeutic Medicine|2022|19
RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
|Scientific Reports|2022|18